FDA Watch: FDA Approves Enhanced Cologuard Cancer Test
Test maker Exact Sciences says it expects Cologuard Plus to cut false positives by more than 30 percent
Keeps You Up-to-Date on Federal & State Laws, Regulations, New Legislation, and Court Cases that Affect Your Diagnostic Lab or Pathology Practice
Test maker Exact Sciences says it expects Cologuard Plus to cut false positives by more than 30 percent
From - National Intelligence Report
The FDA broke new ground by allowing marketing of Adaptive Biotechnologies' ClonoSEQ assay, a next generation sequencing (NGS)-based test for…
From - National Intelligence Report
The Millennium Laboratories free point of care test (POCT) cups scandal has been described as the biggest kickback scandal involving…
From - National Intelligence Report
On Oct. 2, CMS proposed revisions to rules for appealing adverse Medicare claim determinations (Proposed Rules). The goal is to speed the process that…
By Nir Kaldero bio
We're now well into the Fourth Industrial Revolution. The First Industrial Revolution was about steam and railroads, the Second about electricity, and the…
From - National Intelligence Report
Lying to a Medicare auditor or otherwise obstructing a Medicare audit is a crime that can get you jailed…
From - National Intelligence Report
Talk of an aging population isn't idle chatter. According to the U.S. Census Bureau, 2030 will mark a significant turning point in…
From - National Intelligence Report
The impact of PAMA (the Protecting Access to Medicare Act) is already being felt in the laboratory industry…